Product Images Desvenlafaxine

This appears to be a chart or table with information related to renal impairment, hepatic impairment, and PK (probably pharmacokinetics) for different populations based on gender and age. The table includes information on mild, moderate, and severe impairment for both renal and hepatic function, as well as end-stage renal disease (ESRD). The PK section includes details on the geometric mean ratio for parameters such as Cmax and AUC, with some data missing. Overall, this table provides information that could be useful for healthcare professionals in determining dosages or treatment plans for patients with impaired renal or hepatic function.*

This text shows the change in CYP3A4 inhibitors due to PK, specifically with regards to Ketoconazole Cmax. It provides information on geometric mean ratios with associated confidence intervals. However, the context and significance of this information is not clear and may require additional information in order to be useful.*